Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 4/20 | 0.61 |
| ▸ | FAAH | O00519 | 3/20 | 0.61 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.50 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.50 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.50 |
| ▸ | DRD2 | P14416 | 1/20 | 0.50 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.50 |
| ▸ | DRD4 | P21917 | 1/20 | 0.50 |
| ▸ | DRD3 | P35462 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28995394 | 0.98 | MGLL (0.59) | MGLLFAAHCHRM2CHRM4CHRM5 | |
| SCHEMBL371216 | 0.93 | MGLL (0.70) | MGLLFAAHCHRM2CHRM4CHRM5 | |
| SCHEMBL735230 | 0.91 | MGLL (0.68) | MGLLFAAHMEN1POLBKMT2A | |
| SCHEMBL5970073 | 0.91 | MGLL (0.68) | MGLLFAAHMEN1POLBKMT2A | |
| SCHEMBL31452685 | 0.91 | MGLL (0.68) | MGLLFAAHMEN1POLBKMT2A | |
| SCHEMBL7198335 | 0.91 | MGLL (0.68) | MGLLFAAHMEN1POLBKMT2A | |
| SCHEMBL7035034 | 0.91 | MGLL (0.68) | MGLLFAAHMEN1POLBKMT2A | |
| SCHEMBL9307539 | 0.91 | MGLL (0.68) | MGLLFAAHMEN1POLBKMT2A | |
| SCHEMBL8862894 | 0.91 | MGLL (0.68) | MGLLFAAHMEN1POLBKMT2A | |
| SCHEMBL8863096 | 0.91 | MGLL (0.68) | MGLLFAAHMEN1POLBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107286101-B | 1-aryl aldoxime uracil and its preparation method | 云南大学 | 2020-04-21 | — | — | CN | claimed |
| US-5688312-A | INKS WITH COLORS AND IMIDES OR BISIMIDES, FOR ACOUSTIC INK PRINTER AND DROP EJECTOR | XEROX CORPORATION (US) | 1997-11-18 | — | — | US | claimed |
| US-20250235392-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND A GAMMA-BUTYROLACTONE AND/OR A GAMMA-BUTYROLACTAM | L'OREAL (FR) | 2025-07-24 | — | — | US | disclosed |
| WO-2024044728-A1 | PEGYLATED LIPID COMPOUNDS AND METHODS OF USE THEREOF | RENAGADE THERAPEUTICS MANAGEMENT INC. (US) | 2024-02-29 | — | — | WO | disclosed |
| US-20230372915-A1 | MANGANESE BASED COMPLEXES AND USES THEREOF FOR HOMOGENEOUS CATALYSIS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2023-11-23 | — | — | US | disclosed |
| US-20230372915-A1 | MANGANESE BASED COMPLEXES AND USES THEREOF FOR HOMOGENEOUS CATALYSIS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2023-11-23 | — | — | US | disclosed |
| US-11760775-B2 | Steroids and protein-conjugates thereof | REGENERON PHARMACEUTICALS, INC. | 2023-09-19 | — | — | US | disclosed |
| US-11731116-B2 | Manganese based complexes and uses thereof for homogeneous catalysis | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2023-08-22 | — | — | US | disclosed |
| US-11731116-B2 | Manganese based complexes and uses thereof for homogeneous catalysis | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2023-08-22 | — | — | US | disclosed |
| US-20230045778-A9 | HETEROGENEOUS HYDROGEN-CATALYST SOLID FUEL REACTION MIXTURE AND REACTOR | BRILLIANT LIGHT POWER, INC. (US) | 2023-02-09 | — | — | US | disclosed |
| US-20220175782-A1 | KRAS G12C INHIBITORS AND METHODS OF USING THE SAME | AMGEN INC. | 2022-06-09 | — | — | US | disclosed |
| US-4889646-A | ASHLESS MANNICH REACTION PRODUCT NEUTRALIZED WITH SULFURIC, NITRIC AND HYDROCHLORIC ACID; OIL ADDITIVE PACKAGE; | AMOCO CORPORATION (US) | 1989-12-26 | — | — | US | disclosed |
| US-4841069-A | Ammonolysis-alkylation reactions using ammonia and an alcohol to prepare N-alkyl maleimides and N-alkyl succinimides | AMOCO CORPORATION (US) | 1989-06-20 | — | — | US | disclosed |
| EP-0297495-A2 | Nitrogen containing dispersants treated with mineral acids and lubricating compositions containing the same | AMOCO CORPORATION (US) | 1989-01-04 | — | — | EP | disclosed |
| US-4757146-A | Method for the preparation of quinoline-2,3-dicarboxylic acid | AMERICAN CYANAMID COMPANY (US) | 1988-07-12 | — | — | US | disclosed |
| EP-0257433-A2 | Method for the preparation of quinoline-2,3-dicarboxylic acid | AMERICAN CYANAMID COMPANY (US) | 1988-03-02 | — | — | EP | disclosed |
| EP-0257940-A2 | A method of analyzing high molecular weight dispersants in motor oils | The Lubrizol Corporation (US) | 1988-03-02 | — | — | EP | disclosed |
| US-4710474-A | OXIDIZING METAL DIALKYL DITHIOPHOSPHATE, DIALYSIS, ACIDIFICATION, ION EXCHANGE CHROMATOGRAPHY, SPECTROGRAPHIC ANALYSIS OF HYDROCARBYL SUCCINIMIDE | THE LUBRIZOL CORPORATION (US) | 1987-12-01 | — | — | US | disclosed |
| US-4204970-A | Lubricant compositions containing alkylated aromatic amino acid antioxidants | STANDARD OIL COMPANY (INDIANA) (US) | 1980-05-27 | — | — | US | disclosed |
| US-4025452-A | DISPERSANT AND VISCOSITY-IMPROVING ADDITIVE FOR LUBRICANT | MOBIL OIL CORPORATION (US) | 1977-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230372915-A1 | MANGANESE BASED COMPLEXES AND USES THEREOF FOR HOMOGENEOUS CATALYSIS | ADH1C, OTC, MLEC | MGLL 357/4885FAAH 3628/4885CHRM2 3258/4885 |
| US-20250235392-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND A GAMMA-BUTYROLACTONE AND/OR A GAMMA-BUTYROLACTAM | KRT18, YWHAZ, BTN3A1 | MGLL 2079/4885FAAH 3631/4885CHRM2 137/4885 |
| US-20220175782-A1 | KRAS G12C INHIBITORS AND METHODS OF USING THE SAME | KRAS, NRAS, HRAS | MGLL 1796/4885FAAH 1673/4885CHRM2 4864/4885 |
| US-11731116-B2 | Manganese based complexes and uses thereof for homogeneous catalysis | ADH1C, OTC, ADH5 | MGLL 333/4885FAAH 3840/4885CHRM2 3252/4885 |
| US-11760775-B2 | Steroids and protein-conjugates thereof | SERPINA6, NR3C1, NR3C2 | MGLL 2400/4885FAAH 4189/4885CHRM2 4692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.